β2-agonist-induced inhibition of neutrophil chemotaxis is not associated with modification of LFA-1 and Mac-1 expression or with impairment of polymorphonuclear leukocyte antibacterial activity  by SILVESTRI, M. et al.
RESPIRATORY MEDICINE (1999) 93, 416–423â2-agonist-induced inhibition of neutrophil
chemotaxis is not associated with modification of
LFA-1 and Mac-1 expression or with impairment of
polymorphonuclear leukocyte antibacterial activity
M. SILVESTRI, S. ODDERA, S. LANTERO AND G. A. ROSSI
Divisione di Pneumologia, Istituto G. Gaslini, Genoa, Italy
Patients with chronic obstructive lung disorders often show increased susceptibility to airway infections. As
â2-adrenoceptor agonists, in addition to reversing the contractile response of bronchial smooth muscles, may inhibit
a variety of inflammatory and immuno-eVector cell functions, it is possible that these drugs interfere with host
defence mechanisms.
The present study was designed to test in vitro whether fenoterol, a short-acting â2-adrenoceptor agonist, could
modify human blood neutrophil recruitment and antimicrobial activity.
Pre-exposure to fenoterol significantly reduced neutrophil migration towards the complement component C5a, at
concentrations ranging from 10"7 m to 10"5 m, or towards lipopolysaccharide, at a concentration of 10"5 m
(P<0·05, each comparison). In contrast, the drug (10"8–10"5 m) did not significantly modify the increased
expression of lymphocyte function-associated antigen (LFA-1, i.e. CD11a/CD18) the macrophage antigen-1 (Mac-1,
i.e. CD11b/CD18) induced by N-formylmethionylleucylphenylalanine (fMLP) (P>0·05, each comparison). Finally,
incubation of neutrophils with fenoterol (10"8–10"5 m) did not significantly influence phagocytosis or intracellular
killing of bacteria (Staphylococcus aureus) or H2O2 release induced by tetradecanoyl-phorbol-acetate (P>0·1 for
each comparison).
These results suggest that short-acting â2-adrenoceptor agonists, such as fenoterol, are able partially to reduce
neutrophil recruitment in the airways without interfering with the processes involved in phagocytic activity against
bacteria.
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The progressive tissue damage which characterizes chronic
bronchitis is related, at least in part, to the presence of
excessive numbers of activated polymorphonuclear leuko-
cytes, such as neutrophils (1,2). Indeed, in addition to their
phagocytic activity, neutrophils also act as secretory cells
able to release preformed proteins stored in the cytoplasmic
granules as well as toxic oxygen radicals (3–5). The granule-
associated preformed proteins, including cathepsin G,
elastase, proteinase-3, collagenase and gelatinase, damage
bronchial and lung connective tissue components (6–8),
while oxygen radicals, such as superoxide anion (O2
"),
hydrogen peroxide (H2O2), hydroxyl radicals (OH
"),0954-6111/99/060416+08 $12.00/0hypochlorous acid (HClO"), are highly toxic for ciliated
epithelial cells (4,5).
In addition to their potential role in damaging human
tissues, neutrophils can also protect the host against infec-
tion (9). The usual steps resulting in pathogen clearance are
neutrophil recruitment into the involved tissues, phago-
cytosis of invading micro-organisms, release of proteinases
and generation of oxygen metabolites (4,9). However, when
neutrophil recruitment and activation is continuous or
excessive, dysfunctions of the host defence mechanisms can
be hypothesized while the exaggerated inflammatory
response may contribute to tissue damage (3,10). This
phenomenon has been described in subjects with cystic
fibrosis and with bronchiectasis (11,12) and recently
demonstrated in chronic bronchitis patients colonized by
Streptococcus pneumoniae (13).
Neutrophil dysfunction may be induced or enhanced by
drugs administered to patients with chronic inflammatory
diseases of the airways. Drugs able to interfere with
neutrophil functions include corticosteroids (14,15), anti-
biotics (16) and â2-adrenoceptor agonists, which are often
prescribed to treat reversible airway obstruction in chronic? 1999 W. B. SAUNDERS COMPANY LTD
FENOTEROL AND NEUTROPHIL FUNCTIONS 417airway diseases (17). Indeed, it has been demonstrated that
â2-adrenoceptor agonists are able to modulate the functions
of a variety of cells, including phagocytes (17–20).
The present study was designed to evaluate whether
fenoterol, a short-acting â2-adrenoceptor agonist, interferes
with neutrophil functions and therefore facilitates the recur-
rence of respiratory infections associated with chronic
airway diseases.
Using blood neutrophils isolated from healthy volun-
teers, we tested the in vitro the eVect of fenoterol on: 1. the
cell chemotaxis; 2. the expression of adhesion molecules
[lymphocyte function-associated antigen (LFA-1 or CD11a/
CD18) and macrophage antigen-1 (Mac-1 or CD11b/
CD18)]; 3. the antimicrobial activity against bacteria
(Staphylococcus aureus); and 4. respiratory burst induced
by tetradecanoylphorbolacetate.Materials and MethodsSTUDY POPULATION
Twenty-five healthy volunteers (14 men and 11 women aged
18–27 years) entered the study. Exclusion criteria were
history of respiratory infection in the previous 4 weeks and
intake of drugs known to aVect biological function of
neutrophils and/or mononuclear cells. The protocol
was approved by the Giannina Gaslini Institute Ethical
Committee and all subjects, after being informed of the
nature and aim of the study, gave written consent.NEUTROPHIL PURIFICATION
The isolation of neutrophils from peripheral blood was
performed by discontinuous Percoll gradients (Pharmacia,
Uppsala, Sweden) (21). Briefly, 10 ml of 6% dextran (PM
70 000, SIFRA SpA, VR, Italy) in 0.9% NaCl were added
to an equal volume of heparinized blood, mixed gently and
incubated at 37)C. After 30–40 min, the upper phase was
collected, washed once in PBS, resuspended in 1·5 ml of
1·070 g ml"1 Percoll with 5% FCS (Flow ICN, Irvine,
Scotland, U.K.) and layered on discontinuous Percoll gradi-
ents with the following volumes and densities (g ml"1):
1·5 ml 1·100, 3 ml 1·090, 3 ml 1·085 and 3 ml 1·080. The
Percoll gradient densities were obtained by mixing nine
parts of Percoll with one part of 10# HBSS (90% Percoll)
and then diluting the 90% Percoll solution with 1# HBSS
containing 5% FCS. The neutrophils recovered between
1085 and 1080 g/ml"1 of Percoll were washed twice in PBS
and resuspended at 106 cells ml"1 in complete medium.
Neutrophils recovered were 95% pure (the remaining 5%
were mononuclear cells) as established by DiV-Quick stain-
ing (Merz+Dade, Dudingen, Switzerland), and 99% viable,
as determined by the trypan blue dye exclusion test
(Flow ICN).NEUTROPHIL CHEMOTAXIS ASSAY
Neutrophil chemotaxis was tested using 48-well Boyden
microchambers (Neuro Probe Inc., Cabin John, MD,U.S.A.). Fenoterol, kindly provided as pure powder by
Boheringer Ingelheim, Italy, was resuspended in distilled
water to prepare 1 mm stock solution. To evaluate the eVect
of fenoterol on neutrophil chemotaxis, cells were preincu-
bated for 3 h with diVerent concentrations of fenoterol
(from 10"8 to 10"5 m) before performing the assay. Pre-
liminary experiments demonstrated that preincubation of
neutrophils with fenoterol for 3 h did not induce desensi-
tization, as also shown for airway epithelial cells (22). The
lower wells of the Boyden microchambers were loaded with
two diVerent stimuli: 1. C5a (active fragment of comp-
lement cascade) (0·1 mg ml"1, Sigma Chemical Co., St.
Louis, MO, U.S.A.) or 2. lipopolysaccharide (LPS, 0·2 ìg
ml"1, Sigma Chemical Co.) (23). The lower wells were then
covered with a polycarbonate membrane with 3 ìm pores
(Costar Corp., Cambridge, MA, U.S.A.) and 50 ìl aliquots
of cell suspensions (106 cells ml"1) were pipetted into the
upper wells of the chemotaxis chamber. After 30 min incu-
bation at 37)C in 5% CO2, the membrane was detached and
the neutrophils, which had migrated onto the lower side of
the membrane, were fixed, stained with DiV-Quick and
counted under a light microscope. All the experimental
conditions were tested in triplicate and the data expressed
as number of cells migrated in 10 high power fields (HPF,
magnification #400).
Controls were performed by incubating neutrophils with
complete medium for 3 h prior to performing the assay.EXPRESSION OF LYMPHOCYTE
FUNCTION-ASSOCIATED ANTIGEN (LFA-1)
Neutrophils (2#106 cells ml"1) were seeded into 96 round-
bottom well-microtiter plates (Costar Corp.) and pre-
exposed to diVerent concentrations of fenoterol (from 10"8
to 10"5 m) for 3 h. Cells were then stimulated with
N-formylmethionylleucylphenylalanine (fMLP) (Sigma
Chemical Co.) 10"6 m for 1 h. After incubation, the plate
was centrifuged and the cells washed and resuspended in
100 ìl of the staining medium with 1% fetal calf serum
(Biofluids) and 0·2% sodium azide (Sigma Chemical Co.) in
PBS (Flow ICN). The cells were stained with 2·5 ìl of
PE-conjugated monoclonal antibody anti-CD11a (recog-
nizing the Æ1 chain specific to LFA-1) (Serotec, Oxford,
U.K.) and incubated for 30 min at 4)C. The cells were then
washed twice and analysed by flow cytometry using LYSYS
II software (Becton Dickinson Immunocytometry Systems,
Mountain View, CA, U.S.A.) (24). Data are expressed as
mean fluorescence channel (mfc).EXPRESSION OF MACROPHAGE ANTIGEN-1
(MAC-1)
Neutrophils (2#106 cells ml"1) were seeded into 96 round-
bottom well-microtiter plates and pre-exposed to diVerent
concentrations of fenoterol (from 10"8 to 10"5 m) for 3 h.
Cells were then stimulated with fMLP 10"6 m for 5 min.
After incubation, the plate was centrifuged and the cells
washed, resuspended and stained with 2·5 ìl of
418 M. SILVESTRI ET AL.BACTERIAL PREPARATION
Phagocytosis and intracellular killing of bacteria by neu-
trophils were measured as previously described (25). Briefly,
an overnight culture of S. aureus strain ATCC 25923
(Rockville, MD, U.S.A.), kept in 5 ml of BHI broth (Difco
Laboratories, Detroit, Michigan, U.S.A.), was pelleted
(1300#g), resuspended in 5 ml of deionized water and
labelled with 3 ìg ml"1 of 4*, 6*-diamidine-2 phenylindole 2
HCl (DAPI) (Sigma Chemical Co.), a fluorochrome bind-
ing to the A+T-rich regions of double-stranded DNA.
After 10 min incubation at room temperature, bacteria
were washed and resuspended in complete medium without
antibiotics and with 50% human autologous serum at a
concentration of 108 colony-forming units ml"1 at 650 nm.
Bacteria were incubated for 30 min at 37)C in 5% CO2, to
promote opsonization, and then washed. Propidium iodide
(PI) (Sigma Chemical Co.), a viability dye excluded by the
cytoplasmic membrane of live cells but able to bind to
DNA of dead bacteria, was added at a final concentration
of 2 mg ml"1 to the bacterial suspension (DAPI-PI stained
bacteria).NEUTROPHIL PHAGOCYTOSIS AND
INTRACELLULAR KILLING OF BACTERIA
Neutrophils, preincubated with diVerent concentrations of
fenoterol (from 10"8 to 10"5 m) for 3 h, were added to the
DAPI-PI stained bacteria suspension at a final bacteria/
phagocyte ratio of 30:1 (25). After 1 h incubation, 60 ml
aliquots of the neutrophil/bacteria suspensions were col-
lected from the tubes and, mixed with 8 ìl of 3 ìm acridine
orange (Sigma Chemical Co.), to enhance intracellular
details on fluorescence microscopy examination. Cytocen-
trifuge preparations were set, dry-fixed with cyanoacrylate
and evaluated by epi-illumination UV microscopy using
two diVerent filters for DAPI (excitation 365 nm, emission
>420 nm) and PI (excitation 546 nm, emission >590 nm).
With this staining, viable bacteria appear blue, while dead
bacteria appear red. For each experimental condition, a
minimum of 300 neutrophils was evaluated.900
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Fig. 1. Neutrophil locomotion toward C5a (0·1 ìg ml"1)
or lipopolysaccharide (LPS, 0·2 ìg ml"1) and inhibition
of neutrophil chemotaxis in the presence of fenoterol.
(a) Neutrophil locomotion is expressed on the ordinate as
the number of cells counted in 10 high power fields
(HPF), while the diVerent experimental conditions are
shown on the abscissa. (b) The chemotaxis of neutrophils
pretreated with fenoterol toward C5a ( ) or toward LPS
( ) is expressed as a percentage of inhibition on the ordi-
nate, while the diVerent concentrations of fenoterol (from
10"8 to 10"5 m) are shown on the abscissa. In (a), the
data, expressed as mean&s.e.m., represent the results of
20 experiments, while in (b), each point represents the
mean of 10 experiments. ** =P=0·001 vs. control;
*=P<0·05 vs. control.PE-conjugated monoclonal antibody anti-CD11b (Serotec,
Oxford, U.K.) and incubated as described above.HYDROGEN PEROXIDE PRODUCTION BY
ACTIVATED NEUTROPHILS
In order to evaluate the possible eVects of fenoterol on the
respiratory burst of neutrophils, hydrogen peroxide (H2O2)
production was measured using a colorimetric method,
based on the absorption of red ferrothiocyanate in the
presence of hydrogen peroxide (26). H2O2 production was
evaluated in neutrophils (2#106 cells ml"1 in Krebs–
Ringer phosphate buVer) preincubated with diVerent con-
centrations of fenoterol (from 10"8 to 10"5 m) for 3 h and
stimulated for 1 h with a cell membrane activator,
tetradecanoyl-phorbol-acetate (TPA, 100 ng ml"1) (SigmaChemical Co.). NaN3 2 mm (Sigma Chemical Co.) was
added to each experimental condition to inhibit H2O2
breakdown. After incubation, proteins were precipitated on
ice with trichloroacetic acid (10% w/v, final concentration)
(Carlo Erba Reagents, Milan, Italy) and centrifuged at
1000#g. Then, 0·4 ml of ferrous ammonium sulphate
FENOTEROL AND NEUTROPHIL FUNCTIONS 419STATISTICAL ANALYSIS
Data are expressed as mean&standard error of the mean
(s.e.m.). Statistical comparisons between diVerent culture
conditions were made using the Student’s t-test. Data were
considered significant when the P-value was <0·05.ResultsNEUTROPHIL LOCOMOTION
Both C5a and LPS were able significantly to increase
neutrophil locomotion [random migration (ctr) =20·4&4·6
neutrophils 10HPF"1, C5a=553·2&164·7 neutrophils
10HPF"1, LPS=516·0&201·2 neutrophils 10HPF"1,
P<0·001 for each comparison vs ctr] [Fig. 1(a)]. The
number of neutrophils migrating towards C5a was signifi-
cantly reduced in the presence of fenoterol concentrations
from 10"7 to 10"5 m (P>0·05 for each comparison) [Fig.
1(b)]. A similar eVect of the drug was also observed in
neutrophil chemotaxis towards LPS, even if, under these
experimental conditions, statistical significance was reached
only at the highest concentration, i.e. 10"5 m (P<0·05)
[Fig. 1(b)]. Cell viability, as assessed by the trypan blue
exclusion test, was not altered by any concentration of
fenoterol (P>0·05) (not shown).120
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EXPRESSION
Stimulation of neutrophils with fMLP induced a statisti-
cally significant upregulation of LFA-1 expression being
61·35&1·71 mfc in unstimulated cultures and 87·74&
5·14 mfc in fMLP-stimulated cultures (P<0·01, comparison
with control), [Fig. 2(a)]. Similar results were obtained
when Mac-1 expression was evaluated (P<0·01, compari-
son with control) [Fig. 2(b)]. The presence of fenoterol did
not modify the expression of LFA-1 and of Mac-1 on
stimulated neutrophils [Fig. 2(c)].10 mm and 0·2 ml of potassium thiocyanate 2·5 m (Carlo
Erba Reagents) were added to the cell supernatants. The
absorbance of red ferrothiocyanate complexes was finally
measured spectrophotometrically at 480 nm wavelength
and the values, plotted with a standard calibration curve,
were expressed as H2O2 nmol 10
"6 cells.Fig. 2. CD11a and CD11b expression on neutrophils
stimulated by N-formyl-methionyl-leucyl-phenylalanine
(fMLP). (a) Flow-cytometric histogram of CD11a expres-
sion on neutrophils. The neutrophil number is shown on
the ordinate, while the red fluorescence intensity given by
anti-human CD11a PE-conjugated monoclonal antibody
is shown on the abscissa as mean fluorescence channel
(mfc) of each cell. The peak on the left represents
unstimulated cells (Basal) and the peak on the right indi-
cates neutrophils stimulated with fMLP. (b) Flow-
cytometric histogram of CD11b expression on
neutrophils. The neutrophil number is shown on the ordi-
nate, while the red fluorescence intensity given by anti-
human CD11b PE-conjugated monoclonal antibody is
shown on the abscissa as mfc of each cell. (c) EVect of
fenoterol on CD11a ( ) or CD11b ( ) expressions on
neutrophils stimulated by fMLP. The fluorescence inten-
sity given by anti-human CD11a or anti-human CD11b
PE-conjugated monoclonal antibody is shown on the
ordinate as the mfc of each cell, while the diVerent exper-
imental conditions are expressed on the abscissa. The
data, expressed as mean&s.e.m., represent the results of
18 experiments. *=P<0·01 vs. control.
420 M. SILVESTRI ET AL.NEUTROPHIL PHAGOCYTOSIS AND
INTRACELLULAR KILLING OF
STAPHYLOCOCCUS AUREUS
After 1 h incubation, high proportions (89·7&2·8%) of
neutrophils had detectable bacteria in their cytoplasm [Fig.
3(a)]. The number of staphylococci ingested by each phago-
cyte was 27·10&6·2, while intracellular killing, expressed as
percentage of killed bacteria to phagocytized bacteria per
neutrophil ratio, was 8·4&0·7 [Fig. 3(b)]. Fenoterol at all
the concentrations tested did not modify either the propor-
tions of neutrophils ingesting bacteria or the number ofbacteria phagocytized by neutrophils or intracellular killing
(P>0·05, each comparison) [Fig. 3(a) and 3(b)].HYDROGEN PEROXIDE PRODUCTION (H2O2)
The cell membrane activator TPA significantly increased
H2O2 release by neutrophils (P<0·01), [Fig. 3(c)]. This
enhanced neutrophil respiratory burst was not modified by
the presence of fenoterol at any concentration tested
(P>0·05 for each comparison).In
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5Discussion
Evaluation of in vitro blood neutrophils from healthy
volunteers showed that 1. fenoterol decreases neutrophil
locomotion in response to chemotactic signals without
modifying cell ability to express adhesion molecules, and 2.
it does not influence the antimicrobial activity of neu-
trophils, i.e. phagocytosis and intracellular killing of
bacteria and hydrogen peroxide production.
â2-adrenoceptor agonists act through interactions with
specific receptors located in the plasma membranes of
virtually all cell types (27). The binding of agonists to the
receptors activates signal transduction mechanisms which
produce cellular responses that may be diVerent in the
diVerent cell types. In fact, â2-adrenoceptor agonists raise
intracellular cyclic adenosine monophosphate (cAMP) lev-
els by stimulation of adenyl cyclase, and increased cAMP
levels have been associated with inhibition of neutrophil
function (28–30). In addition, â2-adrenoceptor agonists
may increase or decrease the transcription of genes related
to a variety of activities, or may directly modulate receptor
expression (27,30). In this context, there is an increasing
awareness that activation of a surface receptor may modu-
late the activity of other receptors, operating at several
levels in the signal transduction pathway (27,31).Fig. 3. Antibacterial activity of blood neutrophils. (a)
Phagocytozing neutrophils: the percentage of neutrophils
ingesting bacteria is expressed on the ordinate, whereas
the diVerent experimental conditions, [neutrophils in
medium alone (Ctr) and in medium containing diVerent
molar concentrations of fenoterol] are expressed on the
abscissa. (b) Phagocytosis and intracellular killing: the
number of ingested bacteria per cell ( ) and the percent-
age of killed bacteria to phagocytozed bacteria per neu-
trophil ratio ( ) are shown on the ordinates and the
diVerent experimental conditions on the abscissa. (c)
Hydrogen peroxide (H2O2) release: H2O2 release is indi-
cated on the ordinate and expressed as nmol produced by
10
6
cells after 60-min incubation at 37)C, while the diVer-
ent experimental conditions are shown on the abscissa
[neutrophils incubated in medium alone (Ctr), stimulated
with tetradecanoyl-phorbol-acetate (TPA, 100 ng ml"1)
in the presence of diVerent molar concentrations of
fenoterol]. The data, expressed as mean&s.e.m., represent
the results of 12 experiments. *=P<0·01 vs. control.
FENOTEROL AND NEUTROPHIL FUNCTIONS 421Acknowledgements
Supported by a grant from Boheringer Ingelheim, Italy,
and by grant no 56/’94, ‘Ricerca corrente’, Ministero della
Sanita, Rome, Italy.References
1. Thompson AB, Daughton D , Robbins GA, Ghaufouri
MA, Oehlerking M, Rennard SI. Intraluminal airway
inflammation in chronic bronchitis. Characterization
and correlation with clinical parameters. Am Rev
Respir Dis 1989; 140: 1527–1537.
2. Snider GC. Chronic bronchitis and emphysema. In:
Murrey JF, Nadel JA (eds) Textbook of Respiratory
Medicine. Philadelphia: WB Saunders, 1988: 1069–
1106.
3. Weiss SJ. Tissue destruction by neutrophils. N Engl J
Med 1989; 320: 365–376.Previous in vitro studies assessing the eVects of â-agonists
on neutrophil migration and oxygen radical production
have reported conflicting results, possibly because of diVer-
ences in the type of stimulus used to activate neutrophils, in
the source of cells (animals vs. humans) and in the drugs
tested (28,29,32,33). As an example, Ottonello et al. showed
that salmeterol downregulated in vitro the respiratory burst
of human neutrophils, while salbutamol had no such
eVect (17). Although the diVerent activities of these two
â2-agonists may be related to their diVerent pharmacologi-
cal characteristics (a short- vs. a long-acting drug) (33,34),
the authors suggested a second hypothesis, that salmeterol-
mediated inhibition did not occur at the â2-receptor level.
Indeed, they showed that salmeterol activity was not
reversed in the presence of the â-blocker propanolol and did
not correlate with the ability of the drug to increase cAMP
levels (17). In agreement with the data here presented,
preliminary in vivo studies suggest that salmeterol is
indeed able to reduce neutrophil numbers in patients with
neutrophilic airway inflammation (35).
The changes in neutrophil function in response to
adrenoreceptor agonists may also be related to modifi-
cations of the sub-populations of cells evaluated. Indeed, it
was demonstrated ex vivo that the respiratory burst of
polymorphonuclear leukocytes was increased significantly
after i.v. infusion of adrenaline but not of â1- or â2-agonists
(20). In contrast to â1- or â2-agonists, adrenalin, which also
activates Æ-receptors, is able to mobilize the marginating
neutrophil pool, which is rich in functionally active
cells (20).
There is also evidence that multiple regulatory mechan-
isms for cAMP may have diVerent eVects on cell function,
such as adhesion molecule expression. Indeed, in agreement
with the results presented here, Derian et al. found that
isoprenaline was able to downregulate human neutrophil
adhesion to human umbilical vein epithelial cells in vitro
without aVecting the expression of adhesion molecules
LFA-1 and Mac-1 (30). Interestingly, the expression of
LFA-1 and Mac-1 on the neutrophil surface was lowered
in the presence of a phosphodiesterase IV inhibitor
(rolipram) (30).
We observed that relatively high concentrations of
fenoterol (10"5 m) induced a dose-dependent inhibition of
neutrophil chemotaxis while, still maintaining their anti-
bacterial activity, i.e. that they may influence some
neutrophil-induced inflammatory reactions which charac-
terize chronic airway inflammatory disorders without caus-
ing significant dysfunction of the host defence mechanism
against bacteria. The ‘active’ concentrations in our exper-
imental system are probably similar to those obtained in
vivo in clinical practice. Although there are no data on the
pharmacokinetics of fenoterol after inhalation from a
metred dose inhaler (MDI) or from a nebulizer, some
approximations can be made using other â2-adrenergic
drugs. In this context, it has been calculated that after
inhalation of 500 ìg terbutaline sulphate, the amount of the
drug in the large conducting airways is 30–300 ng cm"2
and in the small conducting airways 1–30 ng cm"2 (gen-
erations 9–16) (36,37). This gives approximate drug concen-
trations of 10"4–10"3 m in the fluid of the large airways,and of 10"5–10"4 m in the smaller airways (38). Although
these concentrations may be higher that those obtained in
reality, as they do not take into account uptake of drug
from the ciliary fluid layer, the observation by Masclans et
al. that inhalation of 300 ìg of salbutamol inhibits the
sequestration of labelled neutrophils in the lungs of healthy
subjects after inhalation of platelet-activating factor (39)
supports the results of the present study. These authors
have suggested that the beneficial role of the drug may be
related to its inhibitory activity on airway microvascular
leakage (40), however, a direct eVect on neutrophil chemo-
taxis cannot be excluded.
The dowregulation of neutrophil chemotaxis observed
here in the presence of fenoterol, although statistically
significant, is not impressively so, probably because neu-
trophils were stimulated with two potent chemotactic
stimuli, i.e. LPS and C5a, which are able to increase
neutrophil migration by more than 25-fold. These results
are, however, in agreement with those reported by Derian
et al. who, in evaluating the ability of isoprenaline to
downregulate human neutrophil adhesion to human
umbilical vein epithelial cells in vitro, found an inhibitory
activity similar to that demonstrated by fenoterol in our
study (30).
Finally, a characteristic of many membrane-associated
receptors is desensitization after repeated exposure to or
high-dose administration of agonists: for example â2-
adrenoceptors on inflammatory cells appear to uncouple
rapidly from their intracellular signalling pathways and are
eventually lost from the cell surface (27). This in vitro eVect
of fenoterol may therefore not be clinically relevant to the
regular treatment of chronic bronchitis patients. However,
in agreement with our results, recent clinical trials have
shown that â2-adrenoceptor agonists, when added to other
existing regimens, improve the eVect of therapy in patients
with chronic obstructive pulmonary disease without
increasing the frequency of disease exacerbation (41).
422 M. SILVESTRI ET AL.4. Hogg JC. Neutrophil traYc. In: Crystal RG, West JB
(eds) The Lung, Vol. 1. New York, NY: Raven Press
1991: 565–579.
5. Junod AF. Neutrophils, oxidants and tissue damage.
In: Pozzi E (ed.) Neutrophils, Lymphocytes and Lung.
Milan: Masson, 1990: 49.
6. Travis J. Neutrophil enzimes and emphysema. In: Pozzi
E (ed.) Neutrophils, Lymphocytes and Lung. Milan:
Masson, 1990: 49.
7. McElvaney NG, Crystal RG. Proteases and lung
injury. In: Crystal RG, West JB (eds) The Lung, Vol. 2.
New York, NY: Raven Press: 1991: 2205–2218.
8. Stockley RA. Proteolytic enzymes, their inhibitors and
lung diseases. Clin Sci 1983; 64: 119–126.
9. Wright DG. The neutrophil as a secretory organ of
host defence. In: Gallin J, Fauci AS (eds) Phagocytic
Cells: Advances in Host Defence Mechanisms, Vol. 1.
New York, NY: Raven Press 1982: 75–110.
10. Balbi B, Aufiero A, Pesci A, Oddera S, Zanon P, Rossi
GA, Olivieri D. Evaluation of lower respiratory
tract inflammation in chronic bronchitis by broncho-
alveolar changes associated with local treatment with
Immunytal, a biological response modifier. Chest 1994;
106: 19–26.
11. Eller J, Lapa E, Silva JR, Poulter LW, Lode H, Cole
PJ. Cells and cytokines in chronic bronchial infection.
In: Chignard M, Pretolani M, Renesto P, Vargaftig BB,
(eds) Cells and cytokines in lung inflammation. Ann NY
Acad Sci 1994; 725: 331–345.
12. Fietta A, Bersani C, De Rose V et al. Evaluation
of systemic host defence mechanisms in chronic bron-
chitis. Respiration 1988; 53: 37–43.
13. Riise GC, Ahlstedt S, Larsson S, Enander I, Jones I,
Larsson P, Andersson B. Bronchial inflammation in
chronic bronchitis assessed by measurement of cell
products in bronchial lavage fluid. Thorax 1995; 50:
360–365.
14. Lomas DA, Chambra A, Ip M, Stockley RA. The
eVects of dexamethasone on human neutrophil func-
tions in vitro and in vivo. Agents Actions 1991; 33:
279–285.
15. Llewellyn-Jones CG, Hill SL, Stockley RA. EVects of
fluticasone propionate on neutrophil chemotaxis,
superoxide generation and extracellular proteolytic
activity in vitro. Thorax 1994; 49: 207–212.
16. Hand WL, Hand DL, King-Thompson NL. Antibiotic
inhibition of the respiratory burst response in human
polymorphonuclear leukocytes. Antimicrob Agents
Chemother 1990; 34: 863–870.
17. Ottonello L, Morone P, Dapino P, Dallegri F. Inhibi-
tory eVect of salmeterol on the respiratory burst of
adherent neutrophils. Clin Exp Immunol 1996; 106:
97–102.
18. Lofdahl CG, Chung KF. Long acting â2-
adrenoreceptor agonists: a new perspective in the treat-
ment of asthma. Eur Respir J 1991; 4: 218–226.
19. Mita H, Shida T. Anti-allergic activity of formoterol, a
new beta-adrenoceptor stimulant, and salbutamol in
human leukocytes and human lung tissue. Allergy 1983;
38: 547–553.20. Burns AM, Keogan M, Domaldson M, Brown DL,
Park GR. EVects of inotropes on human leukocyte
numbers, neutrophil function and lymphocyte sub-
types. Br J Anaesthesiol 1997; 78: 530–535.
21. Gartner I. Separation of human eosinophils in density
gradients of polyvinylpyrrolidone-coated silica gel
(Percoll). Immunology 1980; 40: 133–136.
22. Oddera S, Silvestri M, Lantero S, Sacco O, Rossi GA.
Downregulation of the expression of adhesion molecule
(ICAM)-1 on bronchial epithelial cells by fenoterol, a
â2-adrenoceptor agonist. J Asthma 1998; 35: 401–408.
23. Lantero S, Alessandri G, Spallarossa D, Scraso L,
Rossi GA. LFA-1 expression by blood eosinophils is
increased in atopic asthmatic children and is involved
in eosinophil locomotion. Eur Respir J 1998; 12: 1094–
1098.
24. Muirhead KA, Schmitt TC, Muirhead AR. Determi-
nation of linear fluorescence intensities from flow cyto-
metric data accumulated with logarithmic amplifiers.
Cytometry 1983; 3: 251–256.
25. Oddera S, Silvestri M, Sacco O, Eftimiadi C, Rossi GA.
N-acetylcysteine enhances in vitro the intracellular
killing of Staphylococcus aureus by human alveolar
macrophages and blood polymorphonuclear leukocytes
and partially protects phagocytes from self-killing. J
Lab Clin Med 1994; 124: 293–301.
26. Tonetti M, Cavallero A, Botta GA, Niederman R,
Eftimiadi C. Intracellular pH regulates the production
of diVerent oxigen metabolites in neutrophils: eVects
of organic acids produced by anaerobic bacteria.
J Leukocyte Biol 1991; 49: 180–188.
27. Barnes BJ. Beta-adrenergic receptors and their regu-
lation. Am J Respir Crit Care Med 1995; 152: 828–860.
28. Llewellyn-Jones CG, Stockley RA. The eVects of
â2-agonists and methylxantines on neutrophil function
in vitro. Eur Respir J 1994; 7: 1460–1466.
29. Rivkin I, Rosenblatt J, Becker EL. The role of cyclic
AMP in the chemotactic responsiveness and spon-
taneous motility of rabbit peritoneal neutrophils. The
inhibition of neutrophil movement and the evaluation
of cyclic AMP levels by catecholamines, prostaglan-
dins, theophylline and cholera toxin. J Immunol 1975;
115: 1126–1134.
30. Derian CK, Santulli RJ, Rao PE, Solomon HF, Barrett
JA. Inhibition of chemotactic peptide-induced neutro-
phil adhesion to vascular endothelium by cAMP modu-
lators. J Immunol 1995; 154: 308–317.
31. Oddera S, Silvestri M, Scarso L, Testi R, Rossi GA.
Salmeterol inhibits the allergen-induced mononuclear
cell proliferation and downregulates GM-CSF release
and HLA-DR expression by monocytes. Pulm Pharma-
col 1997; 10: 43–49.
32. Nielson CP. â-Adrenergic modulation of the polymor-
phonuclear leukocyte respiratory burst is dependent
upon the mechanism of cell activation. J Immunol 1987;
139: 2392–2397.
33. O’Donnel SR, Wanstall JC. Evidence that the eYcacy
(intrinsic activity) of fenoterol is higher than that of
salbutamol of â-adrenoceptors in guinea-pig trachea.
Eur J Pharmacol 1978; 47: 333–341.
FENOTEROL AND NEUTROPHIL FUNCTIONS 42334. Lipworth B, Grove A. Evaluation of partial â-
receptor agonist activity. Br J Clin Pharmacol 1997; 43:
9–14.
35. Faurschou P, Dahl R, JeVery P, Venge P, Egerod I.
Comparison of the anti-inflammatory eVects of fluti-
casone and salmeterol in asthma: a placebo controlled,
double blind, cross-over study with bronchoscopy,
bronchial methacholine provocation and lavage. Eur
Respir J 1997; 10: 243S (Abstract P1555).
36. Newman SP, Miller AB, Lennard-Jones TR, Moren F,
Clarke SW. Improvement of pressurized aerosol depo-
sition with Nebuhaler spacer device. Thorax 1984; 39:
935–941.
37. Newman SP. Therapeutic aerosols. In: Clarke SW,
Pavia D (eds) Aerosols and the Lung in Clinical and
Experimental Aspects. London: Butterworths, 1984;
197–224.38. Kerrebijn KF. Beta agonists. In: Kaliner MA, Barnes
PJ, Persson CGA, (eds) Asthma: Its Pathology and
Treatment. New York, NY, Maercel Dekker Inc., 1991;
523–545.
39. Masclans JR, Barberà JA, MacNee W, Pavia J, Piera
C, Lomena F, Chung KF, Roca J, Rodriguez-Roisin
R. Salbutamol reduces pulmonary neutrophil seques-
tration of platelet-activating factor in humans. Am J
Respir Crit Care Med 1996; 154: 529–532.
40. Boschetto P, Roberts NM, Rogers DF, Barnes PJ.
EVects of antiasthma drugs on microvascular leakage
in guinea pig airways. Am Rev Respir Dis 1989; 149:
416–421.
41. Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis
N, Crawford C. An evaluation of salmeterol in the
treatment of chronic obstructive pulmonary disease
(COPD). Eur Respir J 1997; 10: 815–821.
